人工细胞纳米医学与生物技术 SCIE

期刊简介预计审稿时间： 20 Weeks

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.

《人造细胞、纳米医学和生物技术》涵盖了跨学科研究和应用的前沿，结合了人造细胞、纳米技术、纳米生物技术、生物技术、分子生物学、生物封装、新型载体、干细胞和组织工程。重点是以下主题的基础研究、应用研究以及临床和工业应用：人造细胞血液替代品和氧疗法纳米技术、纳米生物技术、纳米医学组织工程干细胞生物封装微封装和纳米封装微粒和纳米粒子脂质体细胞疗法和基因疗法酶疗法药物输送系统用于支架和载体的可生物降解和生物相容性聚合物生物传感器固定化酶及其用途其他生物技术和纳米生物技术方法现代研究的快速进步不能孤立地进行，而是基于不同新方法的结合使用。如上所述，涉及新方法的跨学科研究彻底改变了这一领域，从而带来了快速发展。该期刊旨在将这些不同的、现代的和未来的方法汇集到学术界、临床界和工业界，从而使这一高度跨学科的领域得到更大的发展。

《Artificial Cells Nanomedicine And Biotechnology》(人工细胞纳米医学与生物技术)编辑部通讯方式为2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。